Skip to main content
Daniel Orringer, MD, Neurosurgery, New York, NY

DanielAvramOrringerMDFAANS

Neurosurgery New York, NY

Brain & Spinal Tumor

Neurosurgeon, NYU Neurosurgery

Dr. Orringer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Orringer's full profile

Already have an account?

  • Office

    550 First Ave
    Suite 8S, SKI
    New York, NY 10016
    Phone+1 212-263-0909

Education & Training

  • University of Michigan
    University of MichiganResidency, Neurological Surgery, 2004 - 2011
  • University of Michigan Health System
    University of Michigan Health SystemInternship, Transitional Year, 2004 - 2005
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2004

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2019 - 2026
  • MI State Medical License
    MI State Medical License 2004 - 2022
  • MA State Medical License
    MA State Medical License 2011 - 2012
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Recently Viewed (1) Article Information Headings References TrendMD Metrics PubMed Google ScholarNovember 2018

Press Mentions

  • University of Michigan Developed 'Unprecedented' AI Tool to Improve Brain Tumor Surgery
    University of Michigan Developed 'Unprecedented' AI Tool to Improve Brain Tumor SurgeryDecember 10th, 2024
  • AI Testing of Brain Tumors Can Detect Genetic Cancer Markers in Less Than 90 Seconds, Study Finds
    AI Testing of Brain Tumors Can Detect Genetic Cancer Markers in Less Than 90 Seconds, Study FindsApril 3rd, 2023
  • DeepGlioma AI Classifies Brain Tumors Within 90 Seconds—and with 93% Accuracy, Study Finds
    DeepGlioma AI Classifies Brain Tumors Within 90 Seconds—and with 93% Accuracy, Study FindsMarch 27th, 2023
  • Join now to see all

Grant Support

  • Nanoparticle-Enabled Brain Tumor SurgeryNational Cancer Institute2007–2008

Professional Memberships